Healthcare Leaders Income ETF

Healthcare Leaders Income ETF

Healthcare Leaders ETF
Date Symbol NAV ($) NAV Change ($) MKT ($) MKT Change ($) Distribution Total ($)

Fund Quick Facts January 31, 2018

Cusip HHL 42227H101
Cusip HHL.U 42227H200
Net AUM $286.3 million
Management Fee 0.85%
Total Holdings 23
Income Distribution Monthly
Recent Distribution $0.0583
Distribution Method Cash or DRIP

Portfolio Analysis* January 31, 2018

Average Market Capitalization (USD) $119.8B
Number of Equity Securities 20
Average Dividend Yield 2.08%
Average P/E 15.96
5 Year Average Return on Equity 31.70%

Top Ten Holdings

January 31, 2018

Security Portfolio (%)
AbbVie Inc. 5.3
Cash and other assets and liabilities 5.2
Gilead Sciences, Inc. 5.0
Stryker Corporation 5.0
Anthem, Inc. 4.9
Pfizer Inc. 4.9
Novartis AG ADR 4.9
Amgen Inc. 4.9
Medtronic PLC 4.8
AstraZeneca PLC ADR 4.8

Fund Overview

The Fund invests in an equally-weighted portfolio of equity securities of 20 Healthcare Issuers from the Healthcare Leaders Investable Universe that have a minimum market capitalization of US$5 billion at the time of investment and have options in respect of their Equity Securities listed on a recognized options exchange. The portfolio is rebalanced semi-annually back to equal weights.

The Fund’s investment objectives are to provide Unitholders with: (i) the opportunity for capital appreciation; (ii) monthly cash distributions; and (iii) lower overall volatility of Portfolio returns than would otherwise be experienced by owning Equity Securities of the Healthcare Leaders directly.

In order to seek to generate additional returns, the Investment Manager will sell call options each month on Equity Securities held in the Portfolio.

The Fund’s distribution target is $0.0583 per Class A Unit per month ($0.70 per annum) or US$0.0583 per Class U Unit per month (US$0.70 per annum).


Link to prospectus Why Invest

Link to prospectus Quarterly Summary

Link to prospectus Prospectus Eng | Fr

Link to prospectus Summary Documents  HHL EngFr

Link to prospectus Summary Documents  HHL.U Eng | Fr

Portfolio Management

Paul MacDonald Harvest Portfolios Group Inc.


Chief Investment Officer


Portfolio Manager


Portfolio Manager


Associate Portfolio Manager

Investor Suitability

Investors seeking a regular income through investment in the worlds leading healthcare companies.

Investors seeking to hold their investment for medium to long term.



Cumulative Growth $10,000 Invested

January 31, 2018 (NAV pricing)

Historical Prices



Historical Distributions



Portfolio Holdings

Healthcare Leaders Income ETF
as of December 31, 2017

Security % of Portfolio
Pfizer Inc.  5.2
AstraZeneca PLC ADR 5.1
Stryker Corporation 5.1
Johnson & Johnson 5.0
Novartis AG ADR 4.9
AbbVie Inc. 4.9
Amgen Inc. 4.9
Medtronic PLC 4.9
Eli Lilly and Company  4.9
GlaxoSmithKline PLC ADR 4.9
Celgene Corporation 4.9
UnitedHealth Group Inc. 4.8
Anthem, Inc. 4.8
Zoetis Inc. Class A 4.8
Bristol-Myers Squibb Company 4.8
Quest Diagnostic Inc. 4.8
Merck & Co., Inc. 4.8
Gilead Sciences, Inc. 4.7
Boston Scientific Corp. 4.6
Allergan PLC 4.3
Cash and other assets and liabilities 2.7
Foreign Currency Schedule 0.0
Options 0.0

Press Releases


Healthcare Leaders Income ETF

The Fund originally commenced operations as a TSX listed closed-end fund on December 18, 2014 and converted into an exchange-traded fund on October 24, 2016.  Commissions, management fees and expenses all may be associated with investing in HARVEST Exchange Traded Funds. Please read the relevant prospectus before investing. The indicated rates of return are the historical annual compounded total returns including changes in unit value and reinvestment of all distributions and do not take into account income taxes payable by any securityholder that would have reduced returns. The funds are not guaranteed, their values change frequently and past performance may not be repeated. Distributions are paid to you in cash unless you request, pursuant to your participation in a distribution reinvestment plan, that they be reinvested into Class A or Class U units of the Fund. If the Fund earns less than the amounts distributed, the difference is a return of capital. Tax, investment and all other decisions should be made with guidance from a qualified professional.

*Source: Bloomberg.  Average statistics calculated based on portfolio weighted average. Dividend yield based on Bloomberg indicated 12 month yield of portfolios positions and does not represent the distribution yield paid to investors. P/E calculated based on Bloomberg consensus 12 month forward earnings estimates. Return on Equity (ROE) based on 5 year trailing average ROE. The above information is for illustrative purposes only, is estimated and unaudited.